Novo Nordisk’s (CPH: NOVO-B) controlling shareholder, Novo Holdings, has entered into an agreement to purchase a majority stake in Austria-based Single Use Support, a company that supplies equipment and consumables to the biopharmaceutical industry. The financial details of the transaction were not disclosed.
As stated in the press release, Single Use Support specializes in life science tools that are critical for the production of biological drug substances, mRNA vaccines, and cell and gene therapies. The company’s products are engineered to improve operational efficiency, minimize leakage, and reduce the risks of contamination in bioprocessing environments.- Flcube.com
